arising from a deceitful, fraudulent or dishonest act, or having an application for an offer for sale of newly issued securities rejected by the SEC Office on a suspicious ground related to disclosure of
concerning property by a relevant agency, only for a cause arising from a deceitful, fraudulent or dishonest act, or having an application for an offer for sale of newly issued securities rejected by the SEC
complaint or legal prosecution for an offense concerning property by a relevant agency, only for a cause arising from a deceitful, fraudulent or dishonest act, or having an application for an offer for sale
of capital increase from the Initial Public Offering (IPO) in September,2017. Also, repay loans from financial institutions and no incurring interest expense in Q4/2017. Net Profits For the 1st quarter
income totaling Baht 47.79 million was mainly affected by the discontinue of profits from sale of investment assets which had occurred only in the year 2018. Nevertheless, Asia Medical & Agricultural
million or 438.9%. The most of transaction causing from the operational performance from subsidiary company which was fully operational in March 2019, and experiencing accumulated loss. Net Profits For the
baht. 92.65 percent because in the quarter 2 years 2016. The company profits from the sale to a third party the amount of 10.60 million baht. 4. Other income 3.35 million baht Decrease from the same
the parent) of Baht 127 million and Baht 352 million for the second quarter and the first six-month period of 2017, compared to consolidated net profits (attributable to equity holders of the parent
Initial Public Offering (IPO) in September,2017. Also, repay loans from financial institutions and no incurring interest expense in Q4/2017. Net Profits For the 2nd quarter of Year 2017 and 2018, the net
% of the NAV (at the closing of the registrar of unitholders) (2) Provisions for dividend payment (2.1) Where the fund has net profits or retained earnings in the accounting period of dividend payment